Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Aubry

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Presse Medicale (Paris, France : 1983)|November 7, 2006
[Trends in tuberculosis treatment duration]Nicolas Veziris, Alexandra Aubry, Chantal Truffot-Pernot
Infectious Diseases Now|October 15, 2023
Optimizing the use of current antituberculosis drugs to overcome drug resistance in Mycobacterium tuberculosisThomas Maitre, Alain Baulard, Alexandra Aubry, et al.
Journal of Bacteriology|February 3, 2005
Contribution of the ATP binding site of ParE to susceptibility to novobiocin and quinolones in Streptococcus pneumoniaePhilippe Dupont, Alexandra Aubry, Emmanuelle Cambau, et al.
Antimicrobial Agents and Chemotherapy|December 12, 2007
Are all the DNA gyrase mutations found in Mycobacterium leprae clinical strains involved in resistance to fluoroquinolones?Stéphanie Matrat, Emmanuelle Cambau, Vincent Jarlier, et al.
Microbiology Spectrum|April 8, 2017
Mycobacterium marinumAlexandra Aubry, Faiza Mougari, Florence Reibel, et al.
Biochemical and Biophysical Research Communications|August 1, 2006
First functional characterization of a singly expressed bacterial type II topoisomerase: the enzyme from Mycobacterium tuberculosisAlexandra Aubry, L Mark Fisher, Vincent Jarlier, et al.
Bioorganic & Medicinal Chemistry Letters|March 24, 2006
Gatifloxacin derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyraseDharmarajan Sriram, Alexandra Aubry, Perumal Yogeeswari, et al.
Archives of Internal Medicine|August 3, 2002
Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolatesAlexandra Aubry, Olivier Chosidow, Eric Caumes, et al.
Plos Neglected Tropical Diseases|October 19, 2016
Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in MiceAurélie Chauffour, Jérôme Robert, Nicolas Veziris, et al.
Antimicrobial Agents and Chemotherapy|April 23, 2008
Mutagenesis in the alpha3alpha4 GyrA helix and in the Toprim domain of GyrB refines the contribution of Mycobacterium tuberculosis DNA gyrase to intrinsic resistance to quinolonesStéphanie Matrat, Alexandra Aubry, Claudine Mayer, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Presse Medicale (Paris, France : 1983)|November 7, 2006
[Trends in tuberculosis treatment duration]Nicolas Veziris, Alexandra Aubry, Chantal Truffot-Pernot
Infectious Diseases Now|October 15, 2023
Optimizing the use of current antituberculosis drugs to overcome drug resistance in Mycobacterium tuberculosisThomas Maitre, Alain Baulard, Alexandra Aubry, et al.
Journal of Bacteriology|February 3, 2005
Contribution of the ATP binding site of ParE to susceptibility to novobiocin and quinolones in Streptococcus pneumoniaePhilippe Dupont, Alexandra Aubry, Emmanuelle Cambau, et al.
Antimicrobial Agents and Chemotherapy|December 12, 2007
Are all the DNA gyrase mutations found in Mycobacterium leprae clinical strains involved in resistance to fluoroquinolones?Stéphanie Matrat, Emmanuelle Cambau, Vincent Jarlier, et al.
Microbiology Spectrum|April 8, 2017
Mycobacterium marinumAlexandra Aubry, Faiza Mougari, Florence Reibel, et al.
Biochemical and Biophysical Research Communications|August 1, 2006
First functional characterization of a singly expressed bacterial type II topoisomerase: the enzyme from Mycobacterium tuberculosisAlexandra Aubry, L Mark Fisher, Vincent Jarlier, et al.
Bioorganic & Medicinal Chemistry Letters|March 24, 2006
Gatifloxacin derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyraseDharmarajan Sriram, Alexandra Aubry, Perumal Yogeeswari, et al.
Archives of Internal Medicine|August 3, 2002
Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolatesAlexandra Aubry, Olivier Chosidow, Eric Caumes, et al.
Plos Neglected Tropical Diseases|October 19, 2016
Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in MiceAurélie Chauffour, Jérôme Robert, Nicolas Veziris, et al.
Antimicrobial Agents and Chemotherapy|April 23, 2008
Mutagenesis in the alpha3alpha4 GyrA helix and in the Toprim domain of GyrB refines the contribution of Mycobacterium tuberculosis DNA gyrase to intrinsic resistance to quinolonesStéphanie Matrat, Alexandra Aubry, Claudine Mayer, et al.
Pageof 10